Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study
Author:
Publisher
Elsevier BV
Subject
Genetics(clinical),Genetics
Reference50 articles.
1. Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders: an update;Akinci;Recent. Patents Endocr. Metab. Immune. Drug Discov.,2012
2. Cancer-associated thrombosis: clinical presentation and survival;Amer;Cancer Manag. Res.,2013
3. D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer;Batschauer;Ann. Oncol.,2010
4. Relative microvessel area of the primary tumor, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer;Benoy;Breast Cancer Res.,2005
5. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status;Blackwell;J. Clin. Oncol.,2000
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity;Pediatric Blood & Cancer;2024-03-23
2. Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches;Scientific Reports;2023-03-07
3. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review;International Journal of Molecular Sciences;2021-04-01
4. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model;Epigenomics;2020-07
5. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages;Current Problems in Cancer;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3